Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study PDF $40.00
$40.00
× Placeholder The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis PDF $40.00
$40.00
× Placeholder Maternal Postnatal Depression and Completion of Infant Immunizations: A UK Cohort Study of 196,329 Mother-Infant Pairs, 2006–2015 PDF $40.00
$40.00
× Placeholder Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression PDF $40.00
$40.00
× Placeholder Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) PDF $40.00
$40.00
× Placeholder The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines PDF $40.00
$40.00
× Placeholder Longitudinal Follow-Up of Naturalistic Treatment Outcome in Patients With Trichotillomania PDF $40.00
$40.00
× Placeholder Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data PDF $40.00
$40.00
× Placeholder Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder Psychopathology of Seasonal Affective Disorder Patients in Comparison With Major Depression Patients Who Have Attempted Suicide. PDF $40.00
$40.00
× Placeholder Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine PDF $40.00
$40.00
× Placeholder Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits PDF $40.00
$40.00
× Placeholder Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $560.00
Total $560.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe